Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
KALA BIO, Inc. (KALA) had Stock-Based Compensation of $8.55M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$0.69M |
|
-- |
|
-- |
|
$10.22M |
|
$-10.22M |
|
$10.91M |
|
$0.69M |
|
$0.69M |
|
$0.69M |
|
$0.69M |
|
$0.69M |
|
$0.69M |
|
$-10.22M |
|
$-11.31M |
|
8.15M |
|
8.15M |
|
$0.88 |
|
$0.88 |
|
| Balance Sheet Financials | |
$9.49M |
|
-- |
|
-- |
|
$9.49M |
|
$2.49M |
|
-- |
|
-- |
|
$2.49M |
|
$7.00M |
|
$7.00M |
|
$7.00M |
|
27.85M |
|
| Cash Flow Statement Financials | |
$-31.99M |
|
$-0.01M |
|
$-11.62M |
|
$51.18M |
|
$7.56M |
|
$-43.62M |
|
|
Stock-Based Compensation |
$8.55M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-32.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
9.81% |
|
9.81% |
|
7.23% |
|
9.81% |
|
$0.25 |
|
$-3.93 |
|
$-3.93 |
|